By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Rue Pierre et Marie Curie BP 28262
Cedex  Labège-Innopole  31682  France
Phone: 33-5-6128-7060 Fax: 33-5-6128-7069


Company News
Genticel Completes Procervix Phase 2 Study Enrollment Ahead Of Schedule 11/13/2014 1:56:26 PM
Mary Tanner Appointed To Genticel’s Supervisory Board As Independently-Acting Member 9/19/2014 10:25:04 AM
Genticel To Participate In The Rodman & Renshaw Investor Conference In New York – From September 8 To 10 9/8/2014 12:56:03 PM
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014 2:09:02 PM
Genticel’s Phase 2 Study With ProCervix Passes The Halfway Mark For Patient Recruitment 7/10/2014 3:02:56 PM
Eighteen French Biotechs Such As Genticel And Genomic Vision Trek To New York To Hunt For American Investors 6/26/2014 6:50:26 AM
Genticel Reaches An Important Milestone By Launching Its Phase II Trial In Women Infected With High-Risk HPV Before The Appearance Of High Grade Cervical Lesions 3/4/2014 11:11:06 AM
Genticel Appoints Dr Gerald Moeller as Vice-President of Its Supervisory Board 11/7/2013 9:13:20 AM
Genticel Secures $23.7 Million in Capital Funding 4/24/2013 7:24:07 AM
Genticel Announces Positive Data From Its Phase I Trial in Women Infected With High-Risk HPV Before Appearance of Cervical Lesions 10/18/2012 1:05:44 PM